[an error occurred while processing this directive]
血管通路

蚌埠地区老年维持性血液透析患者血管通路调查分析

  • 黄玉萍 ,
  • 徐辉 ,
  • 王道洋 ,
  • 周玉叶 ,
  • 吴雪平 ,
  • 王德光
展开
  • 1蚌埠医学院第二附属医院肾脏内科
    2怀远县中医院肾脏内科
    3蚌埠医学院第一附属医院肾脏内科
    4安徽医科大学第二附属医院肾脏内科

收稿日期: 2021-06-11

  修回日期: 2021-09-28

  网络出版日期: 2021-12-03

基金资助

蚌埠医学院自然科学类项目(BYKF18119)

Investigation of vascular access status in elderly maintenance hemodialysis patients in Bengbu area

  • HUANG Yu-Ping ,
  • XU Hui ,
  • WANG Dao-Yang ,
  • ZHOU Yu-Ye ,
  • WU Xue-Ping ,
  • WANG De-Guang
Expand
  • 1Department of Nephrology, The Second Affiliated Hospital of Bengbu Medical College, Bengbu 233040, China;  2Department of Nephrology, The Traditional Chinese Medicine Hospital of Huaiyuan county, Huaiyuan 233400, China; 3Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China;  4Department of Nephrology, The Second Hospital of Anhui Medical University, Hefei 230601, China

Received date: 2021-06-11

  Revised date: 2021-09-28

  Online published: 2021-12-03

摘要

【摘要】目的分析蚌埠地区老年维持性血液透析(maintenance hemodialysis,MHD)患者的血管通路的情况。方法纳入130 例年龄≥60 岁的MHD 患者作为老年组,162 例年龄<60 岁的MHD 患者作为非老年组。对老年组和非老年组患者首次透析及维持透析血管通路的分布情况进行比较;并对老年MHD 患者动静脉内瘘组及导管组临床资料进行分析。结果蚌埠地区老年MHD 患者血管通路分布中,自体动静脉内瘘(arteriovenous fistula,AVF)占比62.3%,移植物内瘘(arteriovenous graft,AVG)占比0.8%,带隧道带涤纶套导管(tunneled cuffed catheter,TCC)占比36.9%。老年组和非老年组患者首次透析使用临时导管的比例较高;老年组首次透析使用临时导管的比例明显高于非老年组(χ2=18.945,P<0.001),非老年组首次透析使用AVF 比例高于老年组(χ2=17.505,P<0.001)。MHD 血管通路方面老年组TCC 使用率高于非老年组(χ2=27.930,P<0.001)。老年MHD 患者AVF 组血红蛋白(t=-7.712,P<0.001)及白蛋白(t=- 6.323, P<0.001) 明显高于TCC 组;AVF 组糖尿病比例(t=14.857,P<0.001)、hsCRP(t=- 3.172, P=0.002)及血肌酐(t=4.626, P=0.033)明显低TCC 组。结论蚌埠地区老年MHD 患者血管通路构成不太理想,距我国血管通路专家共识推荐的目标还有一定的差距。患者初次血液透析及MHD 的动静脉内瘘使用率较低。MHD 患者采用AVF 通路透析对体内微炎症状态、营养状况及贫血影响较小。临床应将AVF 作为透析患者血管通路的“首要选择”,在此基础之上兼顾“个体化”选择。

本文引用格式

黄玉萍 , 徐辉 , 王道洋 , 周玉叶 , 吴雪平 , 王德光 . 蚌埠地区老年维持性血液透析患者血管通路调查分析[J]. 中国血液净化, 2021 , 20(12) : 835 -838 . DOI: 10.3969/j.issn.1671-4091.2021.12.010

Abstract

【Abstract】Objective To investigate the vascular access situation in elderly maintenance hemodialysis(MHD) patients in Bengbu area. Methods A total of 130 MHD patients over 60 years old were enrolled as the elderly group, and a total of 162 MHD patients less than 60 years old were recruited as the non-elderly group. The distribution of vascular access methods at the beginning of hemodialysis and during MHD period were compared between the two groups. Clinical data in elderly group were compared between the patients using internal fistulas and those using venous catheters. Results Of the vascular access methods in elderly
group, arteriovenous fistula (AVF) accounted for 62.3%, arteriovenous graft (AVG) for 0.8%, and tunneled cuffed catheter (TCC) for 36.9%. The proportion of using provisional venous catheter as vascular access at first was relatively high in both elderly group and non-elderly group, and was higher in elderly group than in non-elderly group (χ2=18.945, P<0.001). The proportion of using AVF as vascular access at first was higher in non-elderly group than in elderly group (χ2=17.505, P<0.001). The proportion of using TCC as vascular access was higher in elderly group than in non-elderly (χ2=27.930, P<0.001). In elderly group, the concentrations of hemoglobin and albumin were higher in the patients with AVF than those with TCC (t=-7.712 and -6.323 respectively; P<0.001); the ratio of diabetes and the concentrations of serum hsCRP and creatinine were lower in the patients with AVF than those with TCC (t=14.857, -3.172 and 4.626 respectively, P<0.001, P=0.002 and P=0.033 respectively). Conclusion The constituents of vascular access methods for elderly MHD patients in Bengbu area were unsatisfactory to the targets recommended by the Expert Consensus on Vascular Access in China. The proportion of using AVF at the beginning of hemodialysis and during MHD was lower, while this vascular access method has less effects on microinflammatory state, nutritional status
and anemia of the patients. Therefore, AVF should be adopted as the first choice of vascular access, on which individualized management can then be taken.

参考文献

参考文献
[1] Polikandrioti M,Koutelekos I,Vasilopoulos G, et al. hemodialysis patients'Information and associated characteristics[J].Mater sociomed,2017,29(3):182-187.DOI:10.5455/ msm.2017.29.182-187.?
[2] Collins AJ, Foley RN, Herzog C, etal. US renal data system 2012 annual data report [J].Am J Kidney Dis ,2013,61 (1 Suppl 1) : A7, el-476. DOI: 10.1053 / j.ajkd.2012.11.031.
[3] 中国医院协会血液净化中心管理分会血液净化通路学组.中国血液透析用血管通路专家共识(第1版)[J].中国血液净化,2014,13(8)549-558.DOI:10.3969/j.issn.1671-4091.2014.08.001.
[4] 宋岩,李冀军,张壹言,等.局部尿激酶溶栓治疗血液透析患者动 静脉内瘘血栓疗效及治疗方案探讨[J].中国血液净化,2007,6 (11):597-600.
[5] Arhuidese IJ,Cooper MA,Rizwan M,et al.Vascular access for hemodialysis in the elderly[J].J Vasc Surg,2019,69(2):517-525.el.DOI:10.1016/j.jvs.2018.05.219.
[6] Al-Jaishi AA,Oliver MJ, thomas SM,et al. Patency rates of the?arteriovenous fistula for hemodialysis:a systematic review and meta-analysis[J].Am J Kidney Dis ,2014,63(3):464-478.DOI: 10.1053 / j.ajkd.2013.08.023.
[7] Xi W,Harwood L,Diamant MJ,et al. Patient attitudes towards the ?arteriovenous fistula :a qualitative study on ?vascular access ?decision making[J].Nephrol Dial Transplant ,2011,26(10):3302-3308.DOI:10.1093/ndt/gfr055.
[8] Praga M,Merollo JI,Palomares I,et al.Type of ?vascular access and survival among very elderly hemodialysis patients[J]. Nephron Clin Pract,2013,124(1-2):47-53.DOI:10.1159 /000355694.
[9] Canaud B, Tong L,Tentori F, et al.Clinical practices and?outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study(DOPPS) [J] .Clin J
Am Soc Nephrol, 2011, 6 (7): 1651 - 1662. DOI: 10.2215 / CJN.03530410.
[10]? Bae E, Lee ,H, Kim DK ,et al.Autologous arteriovenousfistula is associated with superior outcomes in elderly hemodialysis patients[J].BMC Nephrol, 2018,19 (1):306.DOI: 10.1186 /s12882 - 018 - 1109 – 9
[11] Park J, Kim J, Hwang S, etal. Arteriovenous graft patency outcomes and prognostic factors [J].Vascular, 2019,27 (2) :128-134. DOI: 10.1177/1708538118807844.
[12] 金其庄,王玉柱,叶朝阳,等.中国血液透析用血管通路专家共识(第2版)[J].中国血液净化,2019,18(6) ,365-381.DOI:10.3969/j.issn.1671-4094.2019.06.001.
[13] 李红.糖尿病微血管病变发病机制和治疗靶点[J].浙江大学学报 (医学版), 2006,35(3):232-235.
[14] Gross ML,Dikow R,Ritz E.Diabetic nephropathy:recent insights into the pathophysiology and the progression of diabetic nephropathy.Kidney Int Suppl,2005,(94): S50-S53.
[15] Sabry AA,Elshafey EM,Alsaran K,et al.The level of C-reactive protein in chronic hemodialysis patients:a comparative study between patients with noninfected catheters and arteriovenous fistula in two large Gulf hemodialysis centers[J].Hemodial Int,2014,18(3):674-679.
[16] Al Saran K, Sabry A,Shalaby M,et al.Level of C-reactive protein in chronic hemodialysis patients:a comparative study between patients with noninfected catheters and arteriovenous fistula in a large Saudi hemodialysis center[J].Ther Apher Dial,2013,17(1):35-39.
[17] Goldstein SL,Ikizler TA,Zappitelli M,et al.Non -infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas[J].Kidney Int , 2009,76(10):1063-1069.
[18] Sachdeva M,Hung A,Kovalchuk O,et al.The initial vascular access type contributes to inflammation in incident hemodialysis patients[J].Int J Nephrol,2012,2012:917 465.
[19] 程亚菲,费晓,徐群红,等.不同血管通路对血液透析患者微炎症状态的影响[J].中国中西医结合肾病杂志,2010,11(2):145-146.
[20] 王革,李凤娥,汤锋,等.带cuff导管血液透析患者微炎症状态、氧化应激与颈动脉硬化的关系[J].临床肾脏病杂志,2013,13(1):28-30.
[21] Lankhorst CE,Wish JB.Anemia in renal disease: diagnosis and management.Blood Rev,2010,24( 1) : 39 - 47.
文章导航

/

[an error occurred while processing this directive]